Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Shayesteh Med AB
AB
Active
Org 5568900673
Stenbocksvägen 4, 906 37
Umeå
Medical specialists activities
· NACE 8622
Est. 2012
0 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Shayesteh Med AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
193
55
0
13
31
Staff expenses
—
—
—
—
—
EBITDA
139
31
−54
−7
14
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
139
31
−54
−7
14
Net financials
2
5
2
1
1
Profit before tax
141
26
−56
−6
15
Tax
−29
−6
−0
−0
−0
Net profit
112
20
−56
−6
15
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
560
372
306
294
313
Equity
515
347
291
285
299
Long-term debt
0
0
0
0
0
Short-term debt
45
25
15
9
13
Total debt
45
25
15
9
13
Financial ratios
5-year trend
EBITDA-margin
45.2%
This company
15.8%
Market median
+186% vs market
2021
2025
Soliditetsgrad
95.5%
This company
38.2%
Market median
+150% vs market
2021
2025
Egenkapitalforrentning
5.0%
This company
18.4%
Market median
-73% vs market
2021
2025
Nettoresultatgrad
48.4%
This company
8.1%
Market median
+498% vs market
2021
2025
Aktivomsætning
0.10×
This company
1.12×
Market median
-91% vs market
2021
2025
Gæld/egenkapital
0.05×
This company
0.62×
Market median
+92% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Shayesteh Med AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
